65th ASH Annual Meeting & Exposition: 904. Outcomes Research – Non-Malignant Conditions: Across the Age Spectrum: Thromboembolism Outcomes in Adult and Pediatric Patients

Symposia: Outcomes Research—Non-Malignant Conditions Oral and Poster Abstracts
Oral

Bleeding and Clotting, Research, Clinical Practice (Health Services and Quality), thromboembolism, Diseases, thrombotic disorders

Pacific Ballroom Salons 18-19 (Marriott Marquis San Diego Marina)

Moderators:

Ang Li, MD, MS, Baylor College of Medicine and Oluwatoyosi Onwuemene, MD, Duke University

Disclosures:

Onwuemene: Sanofi: Honoraria.

This session includes abstracts that assess VTE in neonates, women ages 18-44 and all adults.

9:30 AM

133

Increased Neonatal Mortality and Increasing Rate of Cerebral Venous Sinus Thrombosis in Hospitalized Children: A Pediatric Health Information System Database Study

Jiasen He, MD^1,2, Natalie A Montanez^1,3,4^*, Stuart Fraser, MD^1,4^*, Audrey Barnett^5,6^*, Christin Silos, MS^1,4^*, Keely Smith, MD^1,4^* and Lakshmi Venkat Srivaths, MD^1,3,4

¹University of Texas Health Science Center at Houston, Houston, TX
²MD Anderson Cancer Center, Houston, TX
³Gulf States Hemophilia and Thrombophilia Center, Houston, TX
⁴UTHealth Institute for Stroke and Cerebrovascular Disease, Houston, TX
⁵Memorial Hermann Health System, Houston, TX
⁶Texas EMS, Acute Care, and Trauma Foundation (TETAF), Houston, TX

9:45 AM

134

Prevalence and Impact of COVID-19 in Young Women of Reproductive Age [18-44 Years] Hospitalized with Pulmonary Embolism in the US in 2020 Using National Inpatient Sample Dataset, in-Hospital Mortality, Racial Disparity and Predictors of Mortality

Ummul Z Asfeen, DO¹^*, Kanishka Uttam Chandani, MD²^*, Kalaivani Babu³^*, Maithri Vallabhaneni, MBBS⁴^*, Pratiksha Shankarlal Nathani, MBBS⁵^*, Beenish Najam, MBBS⁶^*, Sai Gautham Kanagala, MBBS⁷^*, Srinishant Rajarajan, MBBS³^*, Zainab Muslehuddin, MD⁸^*, Taherunnisa Rida⁹^*, Akhil Jain, MD¹⁰^* and Rupak Desai, MBBS¹¹^*

¹New York Medical College - Saint Michael's Medical Center, Harrison, NJ
²New York Medical College, Landmark Medical Center, Cumberland, RI
³Sri Ramachandra Medical College and Research Institute, Chennai, India
⁴Baton Rouge General Medical Center, Baton Rouge
⁵Vilasrao Deshmukh Government Medical College, Latur, India
⁶Karachi Medical and Dental College, Karachi, Pakistan
⁷Internal Medicine, Metropolitan Hospital Center, New York, NY
⁸Sinai Grace Hospital, Wayne State University, Detroit Medical Center, West Bloomfield, MI
⁹University Of Texas at Dallas, Richardson, TX
¹⁰Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
¹¹Independent Researcher, Outcomes Research, Atlanta, GA

10:00 AM

135

A Comparison of Bleeding Events Among Patients on Apixaban, Rivaroxaban, and Warfarin for Atrial Fibrillation and/or Venous Thromboembolism

Jordan K Schaefer, MD¹, Josh Errickson, PhD²^*, Xiaowen Kong, MA³^*, Mona A Ali, PharmD⁴^*, Naina Chipalkatti, MD⁵, Brian Haymart, RN, MS³^*, Scott Kaatz, DO, MSc⁶^*, Gregory D Krol, MD⁷^*, Suman L Sood, MD, MSCE¹, James Froehlich, MD, MPH³^* and Geoffrey D. Barnes, MD, MSc³^*

¹Division of Hematology/Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI
²Consulting for Statistics, Computing, & Analytics Research, University of Michigan, Ann Arbor, MI, University of Michigan, Ann Arbor, MI
³Division of Cardiovascular Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, MI
⁴Department of Heart and Vascular Services, Corewell Health William Beaumont University Hospital, Royal Oak, MI
⁵Department of Internal Medicine, University of Michigan, Ann Arbor, MI
⁶Division of Hospital Medicine, Henry Ford Health, Detroit, MI
⁷Department of Internal Medicine, Henry Ford Health, Detroit, MI

10:15 AM

136

Assessing the Risk of Venous Thromboembolism and Bleeding Among Patients with Myeloproliferative Neoplasms Undergoing Total Knee and Hip Arthroplasty

Josue Marquez¹, Samantha Simon, BA²^*, Jeffrey I. Zwicker, MD³, Brian Hollenbeck, MD²^*, Robert Flaumenhaft, MD, PhD⁴ and Rushad Patell, MBBS⁵

¹The Warren Alpert Medical School of Brown University, Providence, RI
²New England Baptist Hospital, Boston
³Memorial Sloan Kettering Cancer Center, New York, NY
⁴Division of Hemostasis and Thrombosis, Beth Israel Deaconess Medical Center, Boston, MA
⁵Division of Hematology and Hematologic Malignancies, Beth Israel Deaconess Medical Center, Boston, MA

10:30 AM

137

Real-World Analysis of Thromboembolic Event Rates in Patients in the United States with Polycythemia Vera

Andrew T. Kuykendall, MD¹, Abdulraheem Yacoub, MD², Nancy Reaven³^*, Susan Funk³^*, Pedro Oyuela, MD⁴^*, Frank Valone, MD⁴^*, Phil Dinh⁴^*, Lucy Bellamy⁴^*, Nikita Modi, PharmD⁴^*, Arturo Molina, MD, MS, FACP⁴ and Suneel Gupta, PhD⁴

¹Moffitt Cancer Center, Tampa, FL
²The University of Kansas, Westwood, KS
³Strategic Health Resources, La Canada, CA
⁴Protagonist Therapeutics, Inc., Newark, CA

10:45 AM

138

Overall Survival of Warfarin Compared to LMWH/Doacs in Cancer-Associated Venous Thromboembolism: VA Cohort Study

Justine Ryu, MD¹, Jennifer La, PhD²^*, Rushad Patell, MBBS^3,4, Ang Li, MD, MS⁵, Nhan V Do, MD^2,6^*, Mary T Brophy, MD^2,6^*, Nathanael R Fillmore, PhD^2,7,8^* and Jeffrey I. Zwicker, MD^9,10

¹Section of Hematology, Yale University School of Medicine, New Haven, CT
²Massachusetts Veterans Epidemiology Research and Information Center, VA Boston Healthcare System, Boston, MA
³Division of Medical Oncology and Hematology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
⁴Division of Hematology and Hematologic Malignancies, Beth Israel Deaconess Medical Center, Boston, MA
⁵Section of Hematology-Oncology, Department of Medicine, Baylor College of Medicine, Houston, TX
⁶Boston University School of Medicine, Boston, MA
⁷Harvard Medical School, Boston, MA
⁸Dana Farber Cancer Institute, Boston, MA
⁹Beth Israel Deaconess Medical Center Harvard Medical School, Boston, MA
¹⁰Department of Medicine, Weill Cornell Medical College, New York, NY

See more of: Oral and Poster Abstracts

<< Previous Session | Next Session >>

^*signifies non-member of ASH

904.O2.6 904. Outcomes Research – Non-Malignant Conditions: Across the Age Spectrum: Thromboembolism Outcomes in Adult and Pediatric Patients